MedPath

To know the safety of Investigational products on healthy human volunteers

Completed
Conditions
Varied Skin Types
Registration Number
CTRI/2019/07/020075
Lead Sponsor
ITC Life Sciences Technology Centre
Brief Summary

Single Application Semiocclusive, Closed Patch test is conducted to measure the irritation potentialof cosmetic products on the skin

Objective: To evaluatethe irritation potential on healthy human subjects of Skin CareFormulations.

Duration of study: 8 days study

Kinetics: T0 (Evaluation oftest sites by Dermatologist, Patch application)

T1(Patchremoval, Evaluation of test sites by Dermatologist

T2(Evaluationof test sites by Dermatologist and Subject post 24 hrs of patchremoval),

T8 (Evaluation of test sites byDermat and Subject post 1 week of patch removal and tracking the positive cases)

Population 24 healthy subjects(12 males + 12 females)

The test area is checked forerythema and oedema caused due to the products and compared with positivecontrol.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
24
Inclusion Criteria

Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….) Subjects representing varied skin types (ideally equal representation of all 4 skin types – Oily, Normal, Dry and combination) Subjects willing to come for regular follow up and ready to follow instructions during the study period.

Exclusion Criteria

For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic, Being asthmatic, Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing (whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety assessment of productsBaseline,0 hrs,24 hrs and 7 days
Secondary Outcome Measures
NameTimeMethod
Not ApplicableNot Applicable

Trial Locations

Locations (1)

Mascot Spincontrol India Pvt. Ltd.

🇮🇳

(Suburban), MAHARASHTRA, India

Mascot Spincontrol India Pvt. Ltd.
🇮🇳(Suburban), MAHARASHTRA, India
Dr Siddheshwar Mathpati
Principal investigator
022-43349191
siddheshwar@mascotspincontrol.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.